Ace:
News
Day care and treatment
The United States approves the use of Aducanumab: a treatment for Alzheimer's disease
11/06/2021
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.
Thank you so much for your donation
15/10/2020Awareness
Quim and Xènia decided to allocate the money for their guests' gifts to make a generous donation to Fundación ACE.
Dr. Mercè Boada participates in the 1st Alzheimer's Biomarkers Conference
07/10/2020Training
Dr. Mercè Boada participated in the first Alzheimer's Biomarkers conference organized by Roche and targeted to neurologists, analysts and other health professionals involved in Alzheimer's disease
Face-to-face memory workshops are back
05/10/2020Day care and treatment
The users of the Daycare Unit have returned to Fundació ACE to continue their memory workshops in person
You won’t remember the word Coronavirus in 30 years
21/09/2020Awareness
On the occasion of World Alzheimer’s Day, Fundació ACE launches a video with the aim of raise awareness of Alzheimer’s
Fundació ACE, Barcelona City Council and other four organizations launch “Infocanal BCN for Alzheimer’s”, a website to clear up doubts about the disease
21/09/2020SCR
Barcelona for Alzheimer’s Group set up by Fundacio ACE, Barcelona City Council and other organizations, have created a new channel in order to answer doubts about Alzheimer’s